Advertisement
Screener

USANA HEALTH SCIENCES, INC. (USNA) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

USANA HEALTH SCIENCES, INC. Comprehensive Income

USANA HEALTH SCIENCES, INC. (USNA) reported Comprehensive Income of -$20.62 million for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-13

  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-07-04 was -$20.62M, a 257.93% decline year-over-year.
  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-04-04 was $9.26M, a 0.68% decline year-over-year.
  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-01-03 was $1.34M.
  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-27 was -$6.46M, a 137.10% decline year-over-year.
  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2026 was $17.25M, a 47.81% decline from fiscal 2024.
  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $33.05M, a 47.43% decline from fiscal 2023.
  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $62.88M, a 12.08% increase from fiscal 2022.
  • USANA HEALTH SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $56.10M, a 53.47% decline from fiscal 2022.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2026-07-04-$20.62M
10-Q · filed 2026-08-13
-$11.37M
10-Q · filed 2026-08-13
-$10.03M
derived: sum of 3 quarters · filed 2026-08-13
-$16.49M
derived: sum of 4 quarters · filed 2026-08-13
2026-04-04$9.26M
10-Q · filed 2026-05-12
$10.59M
derived: sum of 2 quarters · filed 2026-05-12
$4.13M
derived: sum of 3 quarters · filed 2026-05-12
$17.19M
derived: sum of 4 quarters · filed 2026-08-13
2026-01-03$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$5.13M
derived: sum of 2 quarters · filed 2026-03-16
$7.93M
derived: sum of 3 quarters · filed 2026-08-13
$17.25M
10-K · filed 2026-03-16
2025-09-27-$6.46M
10-Q · filed 2025-11-05
$6.60M
derived: sum of 2 quarters · filed 2026-08-13
$15.92M
10-Q · filed 2025-11-05
$11.40M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-28$13.06M
10-Q · filed 2026-08-13
$22.38M
10-Q · filed 2026-08-13
$17.86M
derived: sum of 3 quarters · filed 2026-08-13
$35.28M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-29$9.32M
10-Q · filed 2026-05-12
$4.80M
derived: sum of 2 quarters · filed 2026-05-12
$22.22M
derived: sum of 3 quarters · filed 2026-05-12
$30.74M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-28-$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$12.90M
derived: sum of 2 quarters · filed 2026-03-16
$21.42M
derived: sum of 3 quarters · filed 2026-03-16
$33.05M
10-K · filed 2026-03-16
2024-09-28$17.42M
10-Q · filed 2025-11-05
$25.93M
derived: sum of 2 quarters · filed 2025-11-05
$37.57M
10-Q · filed 2025-11-05
$60.87M
derived: sum of 4 quarters · filed 2026-03-16
2024-06-29$8.52M
10-Q · filed 2025-08-05
$20.16M
10-Q · filed 2025-08-05
$43.45M
derived: sum of 3 quarters · filed 2026-03-16
$53.05M
derived: sum of 4 quarters · filed 2026-03-16
2024-03-30$11.64M
10-Q · filed 2025-05-06
$34.93M
derived: sum of 2 quarters · filed 2026-03-16
$44.53M
derived: sum of 3 quarters · filed 2026-03-16
$54.38M
derived: sum of 4 quarters · filed 2026-03-16
2023-12-30$23.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$32.89M
derived: sum of 2 quarters · filed 2026-03-16
$42.74M
derived: sum of 3 quarters · filed 2026-03-16
$62.88M
10-K · filed 2026-03-16
2023-09-30$9.60M
10-Q · filed 2024-11-05
$19.45M
derived: sum of 2 quarters · filed 2024-11-05
$39.59M
10-Q · filed 2024-11-05
$59.59M
derived: sum of 4 quarters · filed 2025-03-12
2023-07-01$9.85M
10-Q · filed 2024-08-06
$29.99M
10-Q · filed 2024-08-06
$49.99M
derived: sum of 3 quarters · filed 2025-03-12
$54.38M
derived: sum of 4 quarters · filed 2025-03-12
2023-04-01$20.14M
10-Q · filed 2024-05-07
$40.14M
derived: sum of 2 quarters · filed 2025-03-12
$44.53M
derived: sum of 3 quarters · filed 2025-03-12
$55.01M
derived: sum of 4 quarters · filed 2025-03-12
2022-12-31$20.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12
$24.39M
derived: sum of 2 quarters · filed 2025-03-12
$34.87M
derived: sum of 3 quarters · filed 2025-03-12
$56.10M
10-K · filed 2025-03-12
2022-10-01$4.39M
10-Q · filed 2023-11-07
$14.87M
derived: sum of 2 quarters · filed 2023-11-07
$36.10M
10-Q · filed 2023-11-07
$58.35M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-02$10.48M
10-Q · filed 2023-08-08
$31.71M
10-Q · filed 2023-08-08
$53.96M
derived: sum of 3 quarters · filed 2024-02-27
$80.78M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-02$21.23M
10-Q · filed 2023-05-09
$43.48M
derived: sum of 2 quarters · filed 2024-02-27
$70.30M
derived: sum of 3 quarters · filed 2024-02-27
$112.11M
derived: sum of 4 quarters · filed 2024-02-27
2022-01-01$22.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$49.06M
derived: sum of 2 quarters · filed 2024-02-27
$90.88M
derived: sum of 3 quarters · filed 2024-02-27
$120.59M
10-K · filed 2024-02-27
2021-10-02$26.81M
10-Q · filed 2022-11-08
$68.63M
derived: sum of 2 quarters · filed 2022-11-08
$98.34M
10-Q · filed 2022-11-08
$147.42M
derived: sum of 4 quarters · filed 2023-02-28
2021-07-03$41.82M
10-Q · filed 2022-08-09
$71.52M
10-Q · filed 2022-08-09
$120.61M
derived: sum of 3 quarters · filed 2023-02-28
$157.16M
derived: sum of 4 quarters · filed 2023-02-28
2021-04-03$29.71M
10-Q · filed 2022-05-11
$78.79M
derived: sum of 2 quarters · filed 2023-02-28
$115.35M
derived: sum of 3 quarters · filed 2023-02-28
$143.29M
derived: sum of 4 quarters · filed 2023-02-28
2021-01-02$49.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$85.64M
derived: sum of 2 quarters · filed 2023-02-28
$113.59M
derived: sum of 3 quarters · filed 2023-02-28
$134.94M
10-K · filed 2023-02-28
2020-09-26$36.56M
10-Q · filed 2021-11-10
$64.50M
derived: sum of 2 quarters · filed 2021-11-10
$85.86M
10-Q · filed 2021-11-10
$120.73M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-27$27.95M
10-Q · filed 2021-08-11
$49.30M
10-Q · filed 2021-08-11
$84.17M
derived: sum of 3 quarters · filed 2022-03-01
$102.63M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-28$21.35M
10-Q · filed 2021-05-11
$56.23M
derived: sum of 2 quarters · filed 2022-03-01
$74.69M
derived: sum of 3 quarters · filed 2022-03-01
$90.71M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-28$34.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$53.33M
derived: sum of 2 quarters · filed 2022-03-01
$69.36M
derived: sum of 3 quarters · filed 2022-03-01
$97.01M
10-K · filed 2022-03-01
2019-09-28$18.46M
10-Q · filed 2020-11-03
$34.49M
derived: sum of 2 quarters · filed 2020-11-03
$62.14M
10-Q · filed 2020-11-03
$93.98M
derived: sum of 4 quarters · filed 2021-03-02
2019-06-29$16.03M
10-Q · filed 2020-08-04
$43.68M
10-Q · filed 2020-08-04
$75.53M
derived: sum of 3 quarters · filed 2021-03-02
$100.53M
derived: sum of 4 quarters · filed 2021-03-02
2019-03-30$27.65M
10-Q · filed 2020-05-05
$59.50M
derived: sum of 2 quarters · filed 2021-03-02
$84.50M
derived: sum of 3 quarters · filed 2021-03-02
$108.69M
derived: sum of 4 quarters · filed 2021-03-02
2018-12-29$31.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
$56.85M
derived: sum of 2 quarters · filed 2021-03-02
$81.04M
derived: sum of 3 quarters · filed 2021-03-02
$117.26M
10-K · filed 2021-03-02
2018-09-29$25.00M
10-Q · filed 2019-11-05
$49.20M
derived: sum of 2 quarters · filed 2019-11-05
$85.42M
10-Q · filed 2019-11-05
$82.24M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$24.20M
10-Q · filed 2019-08-06
$60.41M
10-Q · filed 2019-08-06
$57.23M
derived: sum of 3 quarters · filed 2020-02-25
$83.32M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$36.22M
10-Q · filed 2019-05-07
$33.04M
derived: sum of 2 quarters · filed 2020-02-25
$59.12M
derived: sum of 3 quarters · filed 2020-02-25
$84.53M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-30-$3.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$22.90M
derived: sum of 2 quarters · filed 2020-02-25
$48.31M
derived: sum of 3 quarters · filed 2020-02-25
$72.76M
10-K · filed 2020-02-25
2017-09-30$26.09M
10-Q · filed 2018-11-07
$51.49M
derived: sum of 2 quarters · filed 2018-11-07
$75.94M
10-Q · filed 2018-11-07
$90.94M
derived: sum of 4 quarters · filed 2019-02-26
2017-07-01$25.41M
10-Q · filed 2018-08-08
$49.85M
10-Q · filed 2018-08-08
$64.85M
derived: sum of 3 quarters · filed 2019-02-26
$94.09M
derived: sum of 4 quarters · filed 2019-02-26
2017-04-01$24.45M
10-Q · filed 2018-05-09
$39.45M
derived: sum of 2 quarters · filed 2019-02-26
$68.69M
derived: sum of 3 quarters · filed 2019-02-26
$92.89M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$44.24M
derived: sum of 2 quarters · filed 2019-02-26
$68.44M
derived: sum of 3 quarters · filed 2019-02-26
$92.17M
10-K · filed 2019-02-26
2016-10-01$29.24M
10-Q · filed 2017-11-08
$53.44M
derived: sum of 2 quarters · filed 2017-11-08
$77.17M
10-Q · filed 2017-11-08
$99.25M
derived: sum of 4 quarters · filed 2018-02-28
2016-07-02$24.20M
10-Q · filed 2017-08-09
$47.93M
10-Q · filed 2017-08-09
$70.01M
derived: sum of 3 quarters · filed 2018-02-28
$92.46M
derived: sum of 4 quarters · filed 2018-02-28
2016-04-02$23.73M
10-Q · filed 2017-05-10
$45.81M
derived: sum of 2 quarters · filed 2018-02-28
$68.26M
derived: sum of 3 quarters · filed 2018-02-28
$92.47M
derived: sum of 4 quarters · filed 2018-02-28
2016-01-02$22.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$44.53M
derived: sum of 2 quarters · filed 2018-02-28
$68.74M
derived: sum of 3 quarters · filed 2018-02-28
$88.76M
10-K · filed 2018-02-28
2015-10-03$22.45M
10-Q · filed 2016-11-09
$46.66M
derived: sum of 2 quarters · filed 2016-11-09
$66.69M
10-Q · filed 2016-11-09
$84.94M
derived: sum of 4 quarters · filed 2017-03-01
2015-07-04$24.21M
10-Q · filed 2016-08-09
$44.24M
10-Q · filed 2016-08-09
$62.48M
derived: sum of 3 quarters · filed 2017-03-01
$81.84M
derived: sum of 4 quarters · filed 2017-03-01
2015-04-04$20.02M
10-Q · filed 2016-05-11
$38.27M
derived: sum of 2 quarters · filed 2017-03-01
$57.63M
derived: sum of 3 quarters · filed 2017-03-01
$77.47M
derived: sum of 4 quarters · filed 2017-03-01
2015-01-03$18.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$37.61M
derived: sum of 2 quarters · filed 2017-03-01
$57.45M
derived: sum of 3 quarters · filed 2017-03-01
$72.97M
10-K · filed 2017-03-01
2014-09-27$19.36M
10-Q · filed 2015-11-12
$39.20M
derived: sum of 2 quarters · filed 2015-11-12
$54.73M
10-Q · filed 2015-11-12
$74.75M
derived: sum of 4 quarters · filed 2016-03-01
2014-06-28$19.84M
10-Q · filed 2015-08-12
$35.37M
10-Q · filed 2015-08-12
$55.40M
derived: sum of 3 quarters · filed 2016-03-01
$72.97M
derived: sum of 4 quarters · filed 2016-03-01
2014-03-29$15.53M
10-Q · filed 2015-05-13
$35.56M
derived: sum of 2 quarters · filed 2016-03-01
$53.13M
derived: sum of 3 quarters · filed 2016-03-01
$75.67M
derived: sum of 4 quarters · filed 2016-03-01
2013-12-28$20.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
$37.60M
derived: sum of 2 quarters · filed 2016-03-01
$60.14M
derived: sum of 3 quarters · filed 2016-03-01
$77.88M
10-K · filed 2016-03-01
2013-09-28$17.57M
10-Q · filed 2014-11-06
$40.11M
derived: sum of 2 quarters · filed 2014-11-06
$57.85M
10-Q · filed 2014-11-06
$76.57M
derived: sum of 4 quarters · filed 2015-03-17
2013-06-29$22.54M
10-Q · filed 2014-08-05
$40.28M
10-Q · filed 2014-08-05
$59.00M
derived: sum of 3 quarters · filed 2015-03-17
$77.40M
derived: sum of 4 quarters · filed 2015-03-17
2013-03-30$17.74M
10-Q · filed 2014-05-07
$36.47M
derived: sum of 2 quarters · filed 2015-03-17
$54.87M
derived: sum of 3 quarters · filed 2015-03-17
$71.12M
derived: sum of 4 quarters · filed 2015-03-17
2012-12-29$18.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
$37.12M
derived: sum of 2 quarters · filed 2015-03-17
$53.38M
derived: sum of 3 quarters · filed 2015-03-17
$67.53M
10-K · filed 2015-03-17
2012-09-29$18.40M
10-Q · filed 2013-11-07
$34.66M
derived: sum of 2 quarters · filed 2013-11-07
$48.81M
10-Q · filed 2013-11-07
$61.69M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30$16.26M
10-Q · filed 2013-08-08
$30.41M
10-Q · filed 2013-08-08
$43.29M
derived: sum of 3 quarters · filed 2014-03-13
$54.41M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31$14.15M
10-Q · filed 2013-05-07
$27.03M
derived: sum of 2 quarters · filed 2014-03-13
$38.16M
derived: sum of 3 quarters · filed 2014-03-13
$53.38M
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$12.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$24.01M
derived: sum of 2 quarters · filed 2014-03-13
$39.23M
derived: sum of 3 quarters · filed 2014-03-13
$51.23M
10-K · filed 2014-03-13
2011-10-01$11.13M
10-Q · filed 2012-11-07
$26.35M
derived: sum of 2 quarters · filed 2012-11-07
$38.35M
10-Q · filed 2012-11-07
2011-07-02$15.22M
10-Q · filed 2012-08-08
$27.23M
10-Q · filed 2012-08-08
2011-04-02$12.01M
10-Q · filed 2012-05-10
2011-01-01$49.48M
10-K · filed 2013-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Canopy Growth Corp (CGC)$0.395B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87